S. Koshida et al. / Tetrahedron Letters 42 (2001) 1293–1296
1295
Scheme 4.
Furthermore, neutral oligosaccahrides, such as lactose
or maltose, were easy to be assembled by a similar
reaction conditions (data not shown). Therefore, this
method may be applicable not only to sulfated saccha-
rides but also to any oligosaccharides from natural or
synthetic sources, provided that they have reducing
ends.
9. Sulfated disaccharide 1 was synthesized from the interme-
diate in the accompanying manuscript (see Ref. 15)
10. Lane, C. F. Synthesis 1975, 135–146.
11. Borch, R. F.; Bernstein, M. D.; Durst, H. D. J. Am.
Chem. Soc. 1971, 93, 2897–2904.
12. No coupling reaction with m-phenylenediamine (0.4
equiv. to 1) occurred, however, the most of starting
material was recovered under the same conditions applied
for aniline (pH 7, at room temperature). The coupling of
1 with m-phenylenediamine proceeded at 37°C, but only
one of the amino groups of the diamine reacted to give a
small amount of 5: no desired dimeric assembly 6 was
obtained and most of 1 recovered.
13. Linker 7 (0.92 mg, 3.08 mmol) and 1 (5.0 mg, 7.71 mmol)
were dissolved in a mixture of water (0.9 mL) and acetic
acid (0.1 mL). To the solution was added sodium
cyanoborohydride (4.80 mg, 76.4 mmol), and the solution
was heated at 37°C in a sealed tube. After heating for 24
h, sodium cyanoborohydride (4.80 mg, 76.4 mmol) was
added, and the solution was heated again at 37°C in a
sealed tube. After heating for further 24 h, the reaction
solution was concentrated in vacuo. The residue was
dissolved in water and NaHCO3 was added, and chro-
matographed on Sephadex G-50 (1.7 x 90 cm, water) to
give 9 as a white powder (2.84 mg, 58.9% from 7, 47.1%
from 1).
Acknowledgements
This study was supported in part by ‘Research for the
Future’ Program No. 97L00502 from the Japan Society
for the Promotion of Science.
References
1. Lee, Y. C.; Lee, R. T. Acc. Chem. Res. 1995, 28, 321–327.
2. Weis, W. I.; Drickamer, K. Annu. Rev. Biochem. 1996,
65, 441–473.
3. Dimick, S. M.; Powell, S. C.; McMahon, S. A.;
Moothoo, D. N.; Naismith, J. H.; Toone, E. J. J. Am.
Chem. Soc. 1999, 121, 10286–10296.
4. Schwartz, B. A.; Gray, G. R. Arch. Biochem. Biophys.
14. Spectral data for compound 9: 1H NMR (500 MHz,
D2O), l 7.17 (2H, t, J=8.0 Hz), 6.83 (2H, s), 6.78 (2H, d,
J=7.6 Hz), 6.61 (2H, d, J=7.6 Hz), 4.96 (2H, s), 4.43
(2H, dd, J=2.3 Hz, J=8.8 Hz), 4.25–4.16 (8H, m), 4.12
(2H, dd, J=8.9 Hz, J=11.8 Hz), 3.90 (2H, m), 3.84 (2H,
m), 3.74 (2H, m), 3.70 (2H, dd, J=2.4 Hz, J=7.6 Hz),
3.65–3.58 (2H, m), 3.57 (2H, dd, J=6.1 Hz, J=10.7 Hz),
3.31 (2H, b), 3.08 (2H, b), 2.68 (4H, s); ESI–MS (nega-
tive) m/z 714.10 [(M−6Na+4H)2−]. Spectral data for com-
1977, 181, 542–549.
5. Laferriere, C. A.; Roy, R. Methods Enzymol. 1994, 242,
102–108.
6. Hashimoto, Y.; Suzuki, M.; Crocker, P. R.; Suzuki, A. J.
Biochem. 1998, 123, 468–478.
7. Suda, Y.; Marques, D.; Kermode, J. C.; Kusumoto, S.;
Sobel, M. Throm. Res. 1993, 69, 501–508.
8. Koshida, S.; Suda, Y.; Fukui, Y.; Ormsby, J.; Sobel, M.;
Kusumoto, S. Tetrahedron Lett. 1999, 40, 5725–5728.